Gene expression and miRNAs profiling: Function and regulation in human epidermal growth factor receptor 2 (HER2) - positive breast cancer
Author | Sareyeldin, Rasha M. |
Author | Gupta, Ishita |
Author | Al-Hashimi, Israa |
Author | Al-Thawadi, Hamda A. |
Author | Al Farsi, Halema F. |
Author | Vranic, Semir |
Author | Al Moustafa, Ala-Eddin |
Available date | 2020-03-25T12:18:05Z |
Publication Date | 2019 |
Publication Name | Cancers |
Resource | Scopus |
ISSN | 20726694 |
Abstract | Breast cancer is the second most common cause of cancer-related deaths among women worldwide. It is a heterogeneous disease with four major molecular subtypes. One of the subtypes, human epidermal growth factor receptor 2 (HER2)-enriched (HER2-positive) is characterized by the absence of estrogen and progesterone receptors and overexpression of HER2 receptor, and accounts for 15-20% of all breast cancers. Despite the anti-HER2 and cytotoxic chemotherapy, HER2 subtype is an aggressive disease with significant mortality. Recent advances in molecular biology techniques, including gene expression profiling, proteomics, and microRNA analysis, have been extensively used to explore the underlying mechanisms behind human breast carcinogenesis and metastasis including HER2-positive breast cancer, paving the way for developing new targeted therapies. This review focuses on recent advances on gene expression and miRNA status in HER2-positive breast cancer. |
Sponsor | We are thankful to Amal Kassab for her critical reading of the manuscript. The publication of this article was funded by the Qatar National Library. |
Language | en |
Publisher | MDPI AG |
Subject | Biomarkers Breast cancer Gene expression profiling HER2-positive breast cancer Microarray miRNAs |
Type | Article |
Issue Number | 5 |
Volume Number | 11 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [709 items ]
-
Medicine Research [1382 items ]